CN114573641A - Iridium complex derivative, preparation method and application thereof - Google Patents

Iridium complex derivative, preparation method and application thereof Download PDF

Info

Publication number
CN114573641A
CN114573641A CN202210263819.1A CN202210263819A CN114573641A CN 114573641 A CN114573641 A CN 114573641A CN 202210263819 A CN202210263819 A CN 202210263819A CN 114573641 A CN114573641 A CN 114573641A
Authority
CN
China
Prior art keywords
iridium complex
group
coumarin
complex derivative
photoresist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210263819.1A
Other languages
Chinese (zh)
Other versions
CN114573641B (en
Inventor
赵建章
温宇东
霍延平
籍少敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University of Technology
Original Assignee
Dalian University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University of Technology filed Critical Dalian University of Technology
Priority to CN202210263819.1A priority Critical patent/CN114573641B/en
Publication of CN114573641A publication Critical patent/CN114573641A/en
Application granted granted Critical
Publication of CN114573641B publication Critical patent/CN114573641B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0033Iridium compounds
    • C07F15/004Iridium compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0033Iridium compounds
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Materials For Photolithography (AREA)

Abstract

The invention relates to the technical field of photoresist, and relates to an iridium complex derivative, a preparation method and application thereof. According to the invention, by virtue of the property of high molar absorption coefficient of a coumarin derivative, a metal heavy atom iridium atom is introduced to enhance intermolecular cross-over, and through excitation of a triplet state, electron transfer is further initiated and effectively generated by a co-initiator, so that the sensitive wavelength of the photoresist is changed, the yield of photoacid is improved, the photosensitivity of the photoresist composition is improved, and the sensitivity of the photoresist, the crosslinking capability of a monomer, the line width roughness of the photoresist, the resolution and the film forming capability are further enhanced.

Description

Iridium complex derivative, preparation method and application thereof
Technical Field
The invention relates to the technical field of photoresist, in particular to an iridium complex derivative, a preparation method and application thereof.
Background
The photoresist, also called as photoresist, refers to a resist film material whose solubility changes by irradiation or radiation of light sources such as ultraviolet light, excimer laser, electron beam, ion beam, and X-ray. The method is mainly used for the micro-processing of integrated circuits and semiconductor discrete devices, and also has wide application in the manufacturing processes of flat panel displays, LEDs, magnetic heads with inverted buckle packages, precision sensors and the like. According to the difference of photochemical reaction mechanism, the photoresist is divided into a positive photoresist and a negative photoresist: after exposure, the solubility of the photoresist in a developing solution is increased, and the photoresist with the same pattern as the mask is obtained and is called as a positive photoresist; after exposure, the solubility of the photoresist in a developing solution is reduced, even the photoresist is insoluble, and the negative photoresist with a pattern opposite to that of the mask is obtained. Three important parameters of the photoresist include resolution, sensitivity and line width roughness, which determine the process window of the photoresist during chip fabrication.
In photoresist compositions, poor sensitivity can render the monomer insufficiently crosslinked, requiring the addition of a photosensitizer to further adjust its sensitivity. However, excessive amounts of photosensitizer can cause overexposure, and it is important to add the photosensitizer in an appropriate ratio. As the size of the lithographic pattern is required to be smaller and higher, the resolution and edge roughness of the lithographic pattern are required to be higher and higher, and therefore, it is necessary to develop a new photosensitive system to improve the performance of the photoresist.
Disclosure of Invention
In order to solve the problems, the invention provides an iridium complex derivative, a preparation method and application thereof in photoresist, wherein by means of the property of high molar absorption coefficient of a coumarin derivative, a metal heavy atom iridium atom is introduced to strengthen intersystem crossing of the coumarin derivative, and through excitation of a triplet state, electron transfer is further initiated to effectively generate with a coinitiator, so that the sensitive wavelength of the photoresist is changed, the yield of photoacid is improved, the photosensitivity of the photoresist composition is improved, and the sensitivity of the photoresist, the crosslinking capability of a monomer, the line width roughness of the photoresist, the resolution, the film forming capability and the like are further enhanced.
To achieve the purpose, the method is realized by the following technical scheme:
an iridium complex derivative, the structure of which is one of the following formulas:
Figure BDA0003550855280000021
wherein:
R1and R2Selected from hydrogen atoms, C1~C20Alkyl of (C)3~C20Cycloalkyl or a monovalent organic radical having a carbon-carbon unsaturated double bond, R1And R2The same or different; r3、R4、R5And R6Selected from hydrogen atom, methoxy group, phenoxy group, nitro group, cyano group, trifluoromethyl group, carboxyl group, mercapto group, halogen atom or alkyl group, R3、R4、R5And R6The same or different; r7、R8、R9、R10、R11And R12Selected from carbon atoms or nitrogen atoms, R7、R8、R9、R10、R11And R12The same or different.
The alkyl can be methyl, ethyl or propyl, and can also be substituted methyl, ethyl or propyl; c1~C20The alkyl group of (a) may be methyl, ethyl, n-propyl, isopropyl, n-pentyl, dodecyl, octadecyl or eicosyl; c3~C20The cycloalkyl group of (a) may be cyclopropyl, cyclopentyl, cyclodecyl, cyclododecyl or cycloeicosyl; the monovalent organic group having a carbon-carbon unsaturated double bond may be a group in which a hydrogen atom in a vinyl group is partially substituted.
The preparation method of the iridium complex derivative comprises the following specific steps:
the iridium complex derivative with the structure of formula (I) is prepared by mixing coumarin phenanthroline and an iridium complex in a solvent for reaction;
the iridium complex derivative with the structure of formula (II) is prepared by mixing and reacting coumarin iridium complex and 2,2' -bipyridine in a solvent;
the iridium complex derivative with the structure of formula (III) is prepared by mixing coumarin phenanthroline and coumarin iridium complex in a solvent for reaction;
wherein:
the iridium complex is iridium trichloride monohydrate or di-mu-chloro-tetra [2- (2-pyridyl-kN) phenyl-kC ] diidium (III) or di-mu-chloro-tetra [2- (2-pyridyl-kN) pyridyl-kC ] diidium (III);
preferably, the structure of the coumarin phenanthroline is
Figure BDA0003550855280000041
The coumarin iridium complex has a structure of
Figure BDA0003550855280000042
Wherein R1 and R2 are independently selected from hydrogen, C1~C20Alkyl of (C)3~C20A cycloalkyl group or a monovalent organic group having a carbon-carbon unsaturated double bond; r3, R4, R5 and R6 are independently selected from any one of a hydrogen atom, a methoxy group, a phenoxy group, a nitro group, a cyano group, a trifluoromethyl group, a carboxyl group, a mercapto group, a halogen atom or an alkyl group.
Preferably, the solvent is a mixed solvent of dichloromethane and methanol, wherein the volume ratio of dichloromethane to methanol is 2: (0.8 to 1).
Preferably, the molar ratio of the coumarin phenanthroline to the iridium complex, the 2,2' bipyridine or the coumarin iridium complex is 2: (0.8-1).
Preferably, the temperature of the mixing reaction is 40-70 ℃.
Preferably, the mixing reaction time is 5-10 h.
The iridium complex derivative is used as a photosensitizer as a photoresist component, and the photoresist component comprises, by mass, 0.1-5% of the photosensitizer, 3-5% of a photoacid generator, 30-50% of an acidic active resin and 50-70% of an organic solvent.
Preferably, the formula of the photoacid generator is
Figure BDA0003550855280000051
Preferably, the acidic active resin is tetraethylene glycol dimethacrylate, diethylene glycol diacrylate, triethylene glycol diacrylate, tetraethylene glycol diacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, trimethylolpropane triacrylate, tetraethylene glycol dimethacrylate, trimethylolpropane trimethacrylate, 1, 4-butanediol diacrylate, 1, 6-hexanediol diacrylate, 1, 4-butanediol dimethacrylate, 1, 6-hexanediol dimethacrylate, pentaerythritol tetramethacrylate, styrene, divinylbenzene, 4-vinyltoluene, 4-vinylpyridine, N-vinylpyrrolidone, 2-hydroxyethyl methacrylate, 4-vinylpyridine, 1, 6-hexanediol dimethacrylate, and the like, One or more than two of SU-8 resin, 2-hydroxyethyl acrylate, 1, 2-epoxycyclopentane and 3, 4-epoxycyclohexyl formic acid-3 ',4' -epoxycyclohexyl methyl ester; further preferred is SU-8 resin.
Preferably, the organic solvent is one or a mixture of more than two of propylene glycol methyl ether acetate, propylene glycol diacetate, 3-ethoxy-3-imine ethyl propionate, N-methyl pyrrolidone, 2-heptane, 3-heptane, cyclopentanone and cyclohexanone; more preferably, propylene glycol methyl ether acetate and propylene glycol diacetate are mixed, and cyclopentanone and cyclohexanone are mixed.
The invention has the beneficial effects that:
(1) the coumarin group is introduced, has higher molar extinction coefficient in near ultraviolet and visible light regions, has strong absorption characteristic, and can be widely applied to g-line and i-line photoetching. The iridium atoms are introduced to effectively promote the crossing of excited state energy generation systems, so that more energy is distributed on a triplet state, and efficient electron transfer is generated between the iridium atoms and a photoacid generator, thereby promoting the generation of photoacid.
(2) The invention introduces iridium complex derivatives, effectively improves the sensitivity of the photoresist, prepares the photoresist composition with lower photosensitizer dosage, photoacid generator and acid resin, has simple preparation and is easy to obtain micrometer resolution ratio photoetching samples.
Drawings
FIG. 1 is a photograph of an electron scanning lens obtained by photolithography using a photoresist composition of an iridium complex derivative prepared in example 2 of the present invention.
Detailed Description
The present invention will be further described with reference to specific embodiments, but the present invention is not limited to the examples in any way.
Example 1
In a clean 50ml round bottom flask, 87mg coumarin phenanthroline, 208mg coumarin iridium complex are added, and the volume ratio is 2: 1 and a methanol solvent at the reaction temperature of 40 ℃ for 5 hours to obtain the iridium complex derivative shown in the formula (III).
In a new clean 10mL glass bottle, 0.8g trimethylolpropane triacrylate, 1mg iridium complex derivative of formula (III), 100mg iodonium salt, 1.0g propylene glycol methyl ether acetate solvent were added. The mixture was shaken in a glass bottle for 24 hours at room temperature to dissolve it sufficiently. The photoresist solution was then filtered through 0.22 micron and 0.02 micron filters, respectively. After completion, photolithography experiments were performed.
The photoetching experimental method comprises the following steps: the prepared photoresist composition is coated on a quartz silicon wafer at 500 rpm/s; spin-coating at 3000rpm/s to form a film, baking at 95 deg.C on a hot plate for 60 s, and exposing to i-line (365nm) exposure machine for 14 s at a dose of 140mJ/cm2. After exposure, the plate was baked on a hot plate at 95 ℃ for 120 seconds, finally developed in SU-8 developer for 55 seconds and rinsed in isopropanol for 10 seconds.
The structure of the coumarin phenanthroline compound described in this embodiment is:
Figure BDA0003550855280000071
the structure of the coumarin iridium complex compound described in this embodiment is:
Figure BDA0003550855280000072
example 2
In a clean 50ml round bottom flask, 30.2mg of 2,2' -bipyridine, 208mg of coumarin iridium complex were added, and a solution of 2: 0.8 of dichloromethane and methanol solvent, the reaction temperature is 70 ℃, and the reaction time is 10 hours, so as to obtain the iridium complex derivative shown in the formula (II).
In a new clean 10mL glass vial, 1.0g of 1, 2-epoxycyclopentane, 100mg of the iridium complex derivative of formula (II), 100mg of the iodonium salt, 2.0g of equal volume ratio solvents for cyclopentanone and cyclohexanone were added. The mixture was shaken in a glass bottle for 24 hours at room temperature to dissolve it sufficiently. The photoresist solution was then filtered through 0.22 micron and 0.02 micron filters, respectively. After completion, photolithography experiments were performed.
The photoetching experimental method comprises the following steps: the prepared photoresist composition is coated on a quartz silicon wafer at 500 rpm/s; spin-coating at 3000rpm/s to form a film, baking at 105 deg.C on a hot plate for 60 s, and exposing to an i-line (365nm) exposure machine for 15 s at a dose of 150mJ/cm2. After exposure, the plate was baked on a hot plate at 105 ℃ for 120 seconds, finally developed in SU-8 developer for 55 seconds and rinsed in isopropanol for 10 seconds.
The coumarin iridium complex compound described in this embodiment has a structure:
Figure BDA0003550855280000081
example 3
In a clean 50ml round bottom flask, 87mg coumarin phenanthroline, 107mg iridium complex are added, and the volume ratio is 2: 0.8 of dichloromethane and methanol solvent, the reaction temperature is 55 ℃, and the reaction time is 6 hours, so as to obtain the iridium complex derivative shown in the formula (I).
In a new clean 10mL glass vial, 0.7g SU-8 resin, 7.9mg iridium complex derivative of formula (I), 83mg iodonium salt, 1.2g cyclopentanone solvent are added. The mixture was shaken in a glass bottle for 24 hours at room temperature to dissolve it sufficiently. The photoresist solution was then filtered through 0.22 micron and 0.02 micron filters, respectively. After completion, photolithography experiments were performed.
The photoetching experimental method comprises the following steps: the prepared photoresist composition is arranged on a quartz silicon wafer at the speed of 500 rpm/s; spin-coating at 3000rpm/s to form a film, baking at 110 deg.C on a hot plate for 60 s, and exposing to i-line (365nm) exposure machine for 17 s at a dose of 170mJ/cm2. After exposure, baking the substrate on a hot plate at 110 ℃ for 120 seconds, finally developing the substrate in SU-8 developer for 60 seconds, cleaning the substrate in isopropanol for 10 seconds, drying the substrate, carrying out gold spraying treatment on the photoetching sample, and detecting the photoetching result in a scanning electron microscope, wherein the experimental result is shown in figure 1.
The structure of the coumarin phenanthroline compound described in this embodiment is:
Figure BDA0003550855280000091
the iridium complex compound described in this embodiment has the structure:
Figure BDA0003550855280000092

Claims (10)

1. an iridium complex derivative, wherein the structure of the iridium complex derivative is one of the following formulas:
Figure FDA0003550855270000011
wherein:
R1and R2Selected from hydrogen atoms, C1~C20Alkyl of (C)3~C20Cycloalkyl or a monovalent organic radical having a carbon-carbon unsaturated double bond, R1And R2The same or different; r3、R4、R5And R6Selected from hydrogen atom, methoxy group, phenoxy group, nitro group, cyano group, trifluoromethyl group, carboxyl group, mercapto group, halogen atom or alkyl group, R3、R4、R5And R6The same or different; r7、R8、R9、R10、R11And R12Selected from carbon atoms or nitrogen atoms, R7、R8、R9、R10、R11And R12The same or different.
2. An iridium complex derivative according to claim 1, wherein the alkyl group is a methyl, ethyl or propyl group, or a substituted methyl, ethyl or propyl group; c1~C20Alkyl of (a) is methyl, ethyl, n-propyl, isopropyl, n-pentyl, dodecyl, octadecyl or eicosyl; c3~C20Cycloalkyl of (a) is cyclopropyl, cyclopentyl, cyclodecyl, cyclododecyl or cycloeicosyl; the monovalent organic group having a carbon-carbon unsaturated double bond is a case where a hydrogen atom in a vinyl group is partially substituted.
3. The method for producing an iridium complex derivative according to claim 1 or 2, which is characterized by comprising:
the iridium complex derivative with the structure of formula (I) is prepared by mixing coumarin phenanthroline and an iridium complex in a solvent for reaction;
the iridium complex derivative with the structure of formula (II) is prepared by mixing and reacting coumarin iridium complex and 2,2' bipyridine in a solvent;
the iridium complex derivative with the structure of formula (III) is prepared by mixing coumarin phenanthroline and coumarin iridium complex in a solvent for reaction;
wherein:
the iridium complex is iridium trichloride monohydrate or di-mu-chloro-tetra [2- (2-pyridyl-kN) phenyl-kC ] diidium (III) or di-mu-chloro-tetra [2- (2-pyridyl-kN) pyridyl-kC ] diidium (III);
the structure of the coumarin phenanthroline is
Figure FDA0003550855270000021
The coumarin iridium complex has a structure of
Figure FDA0003550855270000031
Wherein R1 and R2 are independently selected from hydrogen, C1~C20Alkyl of (C)3~C20A cycloalkyl group or a monovalent organic group having a carbon-carbon unsaturated double bond; r3, R4, R5 and R6 are independently selected from any one of a hydrogen atom, a methoxy group, a phenoxy group, a nitro group, a cyano group, a trifluoromethyl group, a carboxyl group, a mercapto group, a halogen atom or an alkyl group;
the solvent is a mixed solvent of dichloromethane and methanol.
4. The process for producing an iridium complex derivative according to claim 3,
the volume ratio of the dichloromethane to the methanol is 2: (0.8 to 1);
the molar ratio of the coumarin phenanthroline to the iridium complex to the 2,2' -bipyridine or coumarin iridium complex is 2: (0.8-1).
5. The process for producing an iridium complex derivative according to claim 3 or 4,
the temperature of the mixing reaction is 40-70 ℃;
the mixing reaction time is 5-10 h.
6. The iridium complex derivative as claimed in claim 1 or 2, which is used as a photosensitizer as a photoresist component, wherein the photoresist component comprises, by mass, 0.1% to 5% of the photosensitizer, 3% to 5% of the photoacid generator, 30% to 50% of the acidic reactive resin, and 50% to 70% of an organic solvent.
7. The use of the iridium complex derivative as claimed in claim 6, wherein the photoacid generator has the structural formula
Figure FDA0003550855270000041
8. The use of the iridium complex derivative according to claim 7, wherein the acidic reactive resin is tetraethylene glycol dimethacrylate, diethylene glycol diacrylate, triethylene glycol diacrylate, tetraethylene glycol diacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, trimethylolpropane triacrylate, tetraethylene glycol dimethacrylate, trimethylolpropane trimethacrylate, 1, 4-butanediol diacrylate, 1, 6-hexanediol diacrylate, 1, 4-butanediol dimethacrylate, 1, 6-hexanediol dimethacrylate, pentaerythritol tetramethacrylate, styrene, divinylbenzene, 4-vinyltoluene, 4-vinylpyridine, pentaerythritol, styrene, divinylbenzene, and mixtures thereof, One or more of N-vinyl pyrrolidone, 2-hydroxyethyl methacrylate, SU-8 resin, 2-hydroxyethyl acrylate, 1, 2-epoxycyclopentane, and 3, 4-epoxycyclohexylcarboxylic acid-3 ',4' -epoxycyclohexylmethyl ester.
9. The use of the iridium complex derivative according to claim 7 or 8, wherein the organic solvent is one or more selected from propylene glycol methyl ether acetate, propylene glycol diacetate, ethyl 3-ethoxy-3-imine propionate, N-methylpyrrolidone, 2-heptane, 3-heptane, cyclopentanone, and cyclohexanone.
10. The use of the iridium complex derivative according to claim 9, wherein the organic solvent is a mixture of propylene glycol methyl ether acetate and propylene glycol diacetate, or a mixture of cyclopentanone and cyclohexanone.
CN202210263819.1A 2022-03-17 2022-03-17 Iridium complex derivative, preparation method and application thereof Active CN114573641B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210263819.1A CN114573641B (en) 2022-03-17 2022-03-17 Iridium complex derivative, preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210263819.1A CN114573641B (en) 2022-03-17 2022-03-17 Iridium complex derivative, preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN114573641A true CN114573641A (en) 2022-06-03
CN114573641B CN114573641B (en) 2023-06-13

Family

ID=81779794

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210263819.1A Active CN114573641B (en) 2022-03-17 2022-03-17 Iridium complex derivative, preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN114573641B (en)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JIFU SUN等: "Visible-light harvesting iridium complexes as singlet oxygen sensitizers for photooxidation of 1,5-dihydroxynaphthalene", 《CHEM. COMMUN.》 *
JIFU SUN等: "Visible-Light Harvesting with Cyclometalated Iridium(III) Complexes Having Long-Lived 3IL Excited States and Their Application in Triplet-Triplet-Annihilation Based Upconversion", 《EUR. J. INORG. CHEM.》 *
KEJING XU等: "Switching of the Triplet−Triplet-Annihilation Upconversion with Photoresponsive Triplet Energy Acceptor: Photocontrollable Singlet/Triplet Energy Transfer and Electron Transfer", 《J. PHYS. CHEM. A》 *
MOHAMAD-ALI TEHFE等: "Iridium complexes incorporating coumarin moiety as catalyst photoinitiators: Towards household green LED bulb and halogen lamp irradiation", 《POLYMER》 *

Also Published As

Publication number Publication date
CN114573641B (en) 2023-06-13

Similar Documents

Publication Publication Date Title
CN106715398B (en) Sulfonic acid derivative compounds as photoacid generators in resist applications
JP2919142B2 (en) Photosensitive composition and pattern forming method using the same
JP2501292B2 (en) Method for making acid sensitive polymers and photoresist structures
TW573213B (en) Photoresist composition for deep UV radiation
KR20010028348A (en) Photoresist composition containing photo base generator with photo acid generator
TWI597269B (en) Sulfonic acid derivative compounds as photoacid generators in resist applications
WO2009074522A1 (en) Photoresist compositions and method for multiple exposures with multiple layer resist systems
JPH03289658A (en) Photosensitive composition
US4980264A (en) Photoresist compositions of controlled dissolution rate in alkaline developers
CN103376660A (en) Photoresist composition containing a protected hydroxyl group for negative development and pattern forming method using thereof
KR102546299B1 (en) Cyclic sulfonate compounds as photoacid generators in resist applications
KR100557608B1 (en) Novel photoresist crosslinker and photoresist composition using the same
CN117716292A (en) Enhanced EUV photoresist and method of using the same
JP2001515606A (en) Positive photoresist containing a novel photoactive compound
JPH0643650A (en) Positive type photo-resist composition photosensitized by short wave-length ultraviolet ray
CN114573641B (en) Iridium complex derivative, preparation method and application thereof
CN113214429B (en) ArF photoresist film-forming resin, preparation method thereof and photoresist composition
CN117440944A (en) Oxothiazonium ion-containing sulfonic acid derivative compounds as photoacid generators in resist applications
Lawson et al. Single component molecular resists containing bound photoacid generator functionality
JPH1195436A (en) Pattern forming method
JP2023020960A (en) Resist underlayer film composition and pattern formation method using the same
KR20230077637A (en) Photoacid generator, photoresist composition comprising the same, and method of forming pattern using the same
WO2024010706A1 (en) Enhanced euv materials, photoresists and methods of their use
TW202406905A (en) Enhanced euv photoresists and methods of their use
TW202404974A (en) Enhanced euv photoresists

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant